Emergent BioSolutions Inc., a life sciences company based in Maryland, is dedicated to offering preparedness and response solutions geared towards accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's comprehensive suite of products is designed to address a multitude of PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; public health crises; and acute, emergency, and community care. Notable offerings from Emergent BioSolutions include ACAM2000, a smallpox vaccine; Anthrasil for inhalational anthrax; Botulism Antitoxin Heptavalent to treat botulinum disease; BioThrax, an anthrax vaccine; Ebanga, a monoclonal antibody for Zaire ebolavirus; raxibacumab injection for inhalational anthrax treatment; and TEMBEXA for human smallpox disease treatment. The company also provides NARCAN, a nasal spray for suspected opioid overdose emergencies; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine for the treatment of cholera. Emergent BioSolutions is devoted to innovation and has several promising products currently in development, including AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; EBS-LASV; EGRD-001, a diazepam auto-injector; SIAN, an antidote for acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. In addition to its impressive product offering, Emergent BioSolutions also provides contract development and manufacturing services that encompass drug substance and product manufacturing, packaging, as well as transfer, process, and analytical development services. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Emergent BioSolutions's ticker is EBS
The company's shares trade on the NYSE stock exchange
They are based in Gaithersburg, Maryland
There are 1001-5000 employees working at Emergent BioSolutions
It is emergentbiosolutions.com
Emergent BioSolutions is in the Healthcare sector
Emergent BioSolutions is in the Biotechnology industry
The following five companies are Emergent BioSolutions's industry peers: